Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 9 November 2027
- Last conf. stmt
- 26 October 2026
Osi Midco Limited
- Incorporated
- 26 October 2020 (6 years)
- Industry
- Activities of other holding companies n.e.c. (64209)
- Directors
- Christopher Michael Chambers
- Owned by
- Accounts type
- Small
- Region
- South East
- Address
- 46 Woodstock RoadOxfordOX2 6HT
Charges
- Total
- 2
- Outstanding
- 2
- Part satisfied
- 0
- Satisfied
- 0
Officers 4 active
Officer details are public data from the Companies House register.
British
Born May 1968 (58)
Blakeman, Athene Eliana Georgina
Secretary · Appointed 15 March 2022
Director · Appointed 26 October 2020
British
Born November 1956
Chambers, Christopher Michael
Director · Appointed 26 October 2020
British
Born June 1961 (65)
Officer history (2 former)
24 March 2025
28 February 2023
15 March 2022
Appointed Blakeman, Athene Eliana Georgina as Secretary
15 March 2022
Resigned O'Brien, Kate as Secretary
26 October 2020
26 October 2020
Appointed Chambers, Christopher Michael as Director
26 October 2020
Appointed O'Brien, Kate as Secretary
26 October 2020
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Corporate entity · Notified 26 October 2020
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Public Limited Company
Reg. no. 09093331
Group structure 18 shown
Ownership group derived from the Companies House PSC register
Acionna Therapeutics Ltd Owns 50–75% of shares
Animal Dynamics Limited Owns 50–75% of shares
Archangel Lightworks Ltd Owns 25–50% of shares
Ascension Earth Resources Ltd Owns 25–50% of shares
Caudal Energy Limited Owns 25–50% of shares
Caudal Morlais Limited Owns 75–100% of shares
Circadian Therapeutics Limited Owns 75–100% of shares
Cora Biosciences Limited Owns 25–50% of shares
Credo Therapies Ltd Owns 50–75% of shares
Densix Limited Owns 25–50% of shares
Dyna Therapeutics Limited Owns 50–75% of shares
Eligentis Limited Owns 25–50% of shares
Evox Therapeutics Limited Owns 25–50% of shares
Fluorok Limited Owns 25–50% of shares
Osi Midco Limited This company Owns 75–100% of shares
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 26 October 2026 | Confirmation statement with no updates | 26 October 2026 |
Some other companies at this address
Other companies in this industry
London
London
London
Brentwood
By trade and location
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →